Header Logo

Biosimilars to treat inflammatory arthritis: the challenge of proving identity.

Kay J, Smolen JS. Biosimilars to treat inflammatory arthritis: the challenge of proving identity. Ann Rheum Dis. 2013 Oct; 72(10):1589-93.

View in: PubMed